Michael C. Wu, PhD

Biostatistician
SWOG Statistics and Data Management Center and Fred Hutchinson Cancer Research Center, Seattle, WA, USA, United States

Presentation(s):

• 57: Neoadjuvant Pembrolizumab in Stage II-III Desmoplastic Melanoma (SWOG S1512): Surgical Considerations

  Friday, March 24, 2023
  10:24 AM – 10:34 AM

  Disclosure information not submitted.